NHS To Soon Begin Trial Of World’s First AI Tool To Identify Type 2 Diabetes Risk [Video]

In a groundbreaking medical advancement, the National Health Service (NHS) in England is set to trial an innovative artificial intelligence (AI) tool designed to predict the risk of developing type 2 diabetes up to 13 years before its onset. This pioneering technology, hailed as a potential game-changer in preventive healthcare, is set to begin trials in 2025 at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust.

How the AI Tool Works

The new tool, named Aire-DM, uses cutting-edge AI algorithms to analyze electrocardiogram (ECG) readings taken during routine heart scans. By identifying subtle changes in the heart’s electrical signals—imperceptible to the human eye—the AI system can provide early warnings of a person’s likelihood of developing type 2 diabetes.

These changes, such as prolonged electrical activation times or variations in the heart’s resetting signals, may seem minor but are crucial indicators of how diabetes affects the heart’s structure and function.

The Vision Behind Aire-DM

Dr …

Tags AI, Targeting, Telemedicine